Krsnaa Diagnostics Limited (KRSNAA.BO)
INR 909.8
(-1.02%)
INR 909.8
(-1.02%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 11.71 Billion INR | 28.8% |
| 2022 | 9.09 Billion INR | 3.85% |
| 2021 | 8.76 Billion INR | 44.93% |
| 2020 | 6.04 Billion INR | -4.04% |
| 2019 | 6.29 Billion INR | 19.09% |
| 2018 | 5.28 Billion INR | 79.74% |
| 2017 | 2.94 Billion INR | 67.58% |
| 2016 | 1.75 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 12.94 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 10.75 Billion INR | 0.0% |
| 2023 FY | 11.71 Billion INR | 28.8% |
| 2023 Q4 | 11.71 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 FY | 9.09 Billion INR | 3.85% |
| 2022 Q4 | 9.09 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 9.24 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 8.76 Billion INR | 44.93% |
| 2021 Q4 | 8.76 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 8.76 Billion INR | 0.0% |
| 2020 Q4 | 6.06 Billion INR | 0.0% |
| 2020 FY | 6.04 Billion INR | -4.04% |
| 2019 Q4 | 6.29 Billion INR | 0.0% |
| 2019 FY | 6.29 Billion INR | 19.09% |
| 2018 FY | 5.28 Billion INR | 79.74% |
| 2017 FY | 2.94 Billion INR | 67.58% |
| 2016 FY | 1.75 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Dr. Lal PathLabs Limited | 24.56 Billion INR | 52.284% |
| Metropolis Healthcare Limited | 15.55 Billion INR | 24.639% |
| Thyrocare Technologies Limited | 6.43 Billion INR | -82.008% |
| Vijaya Diagnostic Centre Limited | 9.82 Billion INR | -19.248% |
| Vimta Labs Limited | 4 Billion INR | -192.942% |